|
Charcot-Marie-Tooth Disease
|
C10.574.500.495.200 |
|
|
Hereditary Sensory and Motor Neuropathy
|
C10.574.500.495 |
|
|
Bronchial Fistula
|
C23.300.575.687.225 |
|
|
Respiratory Tract Fistula
|
C23.300.575.687 |
|
|
Dihydralazine
|
D03.383.710.605.500.250 |
|
|
Hydralazine
|
D03.383.710.605.500 |
|
|
Chromohalobacter
|
B03.660.250.350.249 |
|
|
Halomonadaceae
|
B03.660.250.350 |
|
|
Biomedical Engineering
|
H02.070 |
|
|
Health Occupations
|
H02 |
|
|
Alcohol-Related Disorders
|
F03.900.100 |
|
|
Substance-Related Disorders
|
F03.900 |
|
|
CD146 Antigen
|
D23.050.285.439.249 |
|
|
Melanoma-Specific Antigens
|
D23.050.285.439 |
|
|
HIV Reverse Transcriptase
|
D12.776.964.775.562.764.875 |
|
|
pol Gene Products, Human Immunodeficiency Virus
|
D12.776.964.775.562.764 |
|
|
Dual Specificity Phosphatase 3
|
D08.811.641.755.300 |
|
|
Ethics, Dental
|
K01.752.566.479.171.132.500 |
|
|
Ethics, Clinical
|
K01.752.566.479.171.132 |
|
|
Partial Thromboplastin Time
|
E01.370.225.625.115.600 |
|
